Copper(II)–lanthanide(III) 15-metallacrown-5 complexes based on pyrazinohydroxamic acid as new multiple-binding pentagonal platforms with Lewis amphoteric nature

Reaction of copper(II) acetate, lanthanium(III) or gadolinium(III) nitrate (1/5 equiv.) with pyrazinohydroxamic acid (H₂Pyzha) in DMF led to a series of new heterobimetallic 15-metallacrown-5 complexes. In a MeOH/H₂O solution the complexes exist as molecular unassociated metallacrowns. In solid state their structures are more complicated as it has been confirmed by X-ray analysis: discrete molecular metallacrowns [Gd(NO₃)₂{Cu(pyzha)}₅(DMF)₄(NO₃)] · 0.5C₆H₆ · H₂O (1), [Gd(NO₃)₂{Cu(pyzha)}₅(DMF)₅](NO₃) · 1.5DMF · 0.5H₂O (2), [La(NO₃)₂{Cu(pyzha)}₅(DMF)₅]NO₃ · 1.5DMF · 2C₆H₆ (3) are solvates, whereas compound [{La(NO₃)₂{Cu(pyzha)}₅(DMF)₅}₂(μ²-NO₃)](NO₃) · 3DMF (4) is a dimer, where μ-bridged nitrate links two copper centres of the adjacent metallamacrocycles. Complex [Gd(NO₃)₂{Cu(pyzha)}₅(DMF)₂(H₂O)(NO₃)] · CH₂Cl₂ · DMF (5) self-associates into a polymer chain by means of one pyrazine moiety and the copper ring atom. Reaction of the molecular metallacrowns with excess of inorganic salts CdBr₂ or Cu(OAc)₂ proceeds as anion methathesis process affording heteroanionic metallacrowns: molecular [Gd(NO₃)₂{Cu(pyzha)}₅(DMF)₅] [Gd(NO₃)₂{Cu(pyzha)}₅(DMF)₄(H₂O)][CdBr₄] · 1.5DMF (6), and 3D hydrogen bonded polymer [La(μ²-OAc)(H₂O)₃{Cu(pyzha)}₅ (H₂O)₄(NO₃)](NO₃) · 4H₂O (7).     

On the invariant translation approximation property for discrete groups

Recently J.Roe considered the question of whether for a discrete group the reduced group -algebra is the fixed point algebra of Ad acting on the uniform Roe algebra . is said to have the invariant translation approximation property in this case. We consider a slight generalization of this property which, for exact , is equivalent to the operator space approximation property of . We also give a new characterization of exactness and a short proof of the equivalence of exactness of and exactness of for discrete groups.

     

Automated Synthesis of 68Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting

The new minigastrin analog DOTA-MGS8 targeting the cholecystokinin-2 receptor (CCK2R) used in this study displays the combination of two site-specific modifications within the C-terminal receptor binding sequence together with an additional N-terminal amino acid substitution preventing fast metabolic degradation. Within this study, the preparation of ⁶⁸Ga-labeled DOTA-MGS8 was validated using an automated synthesis module, describing the specifications and analytical methods for quality control for possible clinical use. In addition, preclinical studies were carried out to characterize the targeting potential. [⁶⁸Ga]Ga-DOTA-MGS8 showed a high receptor-specific cell internalization into AR42J rat pancreatic cells (~40%) with physiological expression of rat CCK2R as well as A431-CCK2R cells transfected to stably express human CCK2R (~47%). A favorable biodistribution profile was observed in BALB/c nude mice xenografted with A431-CCK2R cells and mock-transfected A431 cells as control. The high tumor uptake of ~27% IA/g together with low background activity and limited uptake in non-target tissue confirms the potential for high-sensitivity positron emission tomography of stabilized MG analogs in patients with MTC and other CCK2R-related malignancies.